Plaquex

Plaquex International is a pharmaceutical company focused on lipid-based therapies, specifically its flagship product Plaquex. The therapy consists of essential phospholipids, primarily polyunsaturated phosphatidylcholine, which is used to treat atherosclerosis by dissolving plaque deposits in the arteries and restoring cell membrane function. It is widely utilized in integrative and cardiovascular medicine to improve blood circulation, lower LDL cholesterol, and support liver health. The company provides its formulations to clinics globally for intravenous administration in patients with chronic vascular conditions. Beyond cardiovascular applications, Plaquex is also employed in anti-aging protocols and the treatment of liver disorders.